Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06661590 · ClinicalTrials.gov registry record · NA
Nutritional Language Model
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06661590: Completed NA study, sponsored by University of Minnesota.
NCT06661590 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06661590, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Colorectal cancer survivors often face unique nutritional challenges and require support in their recovery and long0term health. While human experts have traditionally provided that support, there has been an increase in the use of Large Language Models (LLM) in medicine and in nutrition. The LLM offers a potential supplementary resource for generating personalized nutritional advice, specifically in personalized messaging. However, the efficacy and reliability of these AI-generated messages in comparison to human expert advice remain underexplored specific to this population. This study aims to compare the nutrition-related content generated by popular LLMs-ChatGPT, Claude, Gemini, and Co-Pilot-against messages crafted by human experts. By evaluating the generated content in terms of readability, thematic relevance, medical relevance, perceived effectiveness, and implementation of participants' clinical practice, this research will provide insights into the strengths and limitations of using AI for nutritional guidance in colorectal cancer care.
Primary Outcome
Description: The readability of AI-generated and human expert-generated nutrition messages will be measured using the Flesch-Kincaid Grade Level tool. Unit of Measure: Grade level score (numerical score indicating reading difficulty level). Measurement Tool: Flesch-Kincaid Grade Level formula. Scale values: The values vary from 0 to 18, where 18 represents the most difficult text.
Interventions
- OTHER Nutritional Messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2024-10-15 |
| Est. Completion | 2025-02-06 |
| Phase | NA |
What the finished NCT06661590 record still lists
NCT06661590 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Nutritional Messaging is the first listed.
NCT06661590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06661590 about?
NCT06661590 is a clinical study titled "Nutritional Language Model". Colorectal cancer survivors often face unique nutritional challenges and require support in their recovery and long0term health. While human experts have traditionally provided that support, there has been an increase in the use of Large Language Models (LLM) in medicine and in nutrition. The LLM of...
What is the current status of trial NCT06661590?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2024-10-15. Estimated completion is 2025-02-06.
What interventions are being tested in trial NCT06661590?
The interventions under investigation include: Nutritional Messaging (OTHER).
Who is sponsoring clinical trial NCT06661590?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06661590's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI